Literature DB >> 12525377

Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha.

E M Gravallese1, A R Pettit, R Lee, R Madore, C Manning, A Tsay, J Gaspar, M B Goldring, S R Goldring, P Oettgen.   

Abstract

OBJECTIVES: To examine the potential role of the angiogenic growth factor angiopoietin-1 (Ang-1) in inflammatory arthritis.
METHODS: Eighteen synovial tissue samples were obtained from 17 patients with a clinical diagnosis of rheumatoid arthritis (RA) and compared with six synovial tissue samples from six patients with osteoarthritis (OA). Ang-1 expression in synovial tissues was determined by immunohistochemistry and in situ hybridisation. Ang-1 mRNA and protein expression were also examined by northern blot analysis and enzyme linked immunosorbent assay (ELISA) in cultured synovial fibroblasts and human umbilical vein endothelial cells (HUVECs) before and after treatment with tumour necrosis factor (TNF)alpha.
RESULTS: Ang-1 protein expression was detected by immunohistochemistry in 16/18 RA synovial tissue samples. Ang-1 protein was frequently observed in the synovial lining layer and in cells within the sublining synovial tissue, in both perivascular areas and in areas remote from vessels. In contrast, Ang-1 was only weakly detected in these sites in OA samples. Ang-1 mRNA and protein were also expressed in cultured synovial fibroblasts derived from patients with RA. In addition, induction of Ang-1 mRNA and protein was observed by northern blot analysis and ELISA after stimulation of RA synovial fibroblasts, but not HUVECs, with the proinflammatory cytokine TNF alpha.
CONCLUSIONS: Ang-1 mRNA and protein are expressed in the synovium of patients with RA, and are up regulated in synovial fibroblasts by TNF alpha. Ang-1 may therefore be an important regulator of angiogenesis in inflammatory arthritis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525377      PMCID: PMC1754433          DOI: 10.1136/ard.62.2.100

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage.

Authors:  T Pufe; W Petersen; B Tillmann; R Mentlein
Journal:  Arthritis Rheum       Date:  2001-05

2.  Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells.

Authors:  K Fujikawa; I de Aos Scherpenseel; S K Jain; E Presman; R A Christensen; L Varticovski
Journal:  Exp Cell Res       Date:  1999-12-15       Impact factor: 3.905

3.  The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.

Authors:  A Giatromanolaki; E Sivridis; R Brekken; P E Thorpe; P Anastasiadis; K C Gatter; A L Harris; M I Koukourakis
Journal:  Cancer       Date:  2001-11-15       Impact factor: 6.860

4.  Synovitis occurs in some clinically normal and asymptomatic joints in patients with early arthritis.

Authors:  J A Pando; P Duray; C Yarboro; M F Gourley; J H Klippel; H R Schumacher
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

5.  Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis.

Authors:  J Miotla; R Maciewicz; J Kendrew; M Feldmann; E Paleolog
Journal:  Lab Invest       Date:  2000-08       Impact factor: 5.662

6.  Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis.

Authors:  M Nagashima; J Hasegawa; K Kato; J Yamazaki; K Nishigai; T Ishiwata; G Asano; S Yoshino
Journal:  J Rheumatol       Date:  2001-08       Impact factor: 4.666

7.  In vitro effects of angiopoietins and VEGF on hematopoietic and endothelial cells.

Authors:  X L Huang; N Takakura; T Suda
Journal:  Biochem Biophys Res Commun       Date:  1999-10-14       Impact factor: 3.575

8.  Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.

Authors:  E M Gravallese; C Manning; A Tsay; A Naito; C Pan; E Amento; S R Goldring
Journal:  Arthritis Rheum       Date:  2000-02

9.  Constitutive expression of angiopoietin-1 and -2 and modulation of their expression by inflammatory cytokines in rheumatoid arthritis synovial fibroblasts.

Authors:  Boyd B Scott; Paola F Zaratin; Antonio Colombo; Michael J Hansbury; James D Winkler; Jeffrey R Jackson
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

10.  Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture--primary culture cells markedly differ from fourth-passage cells.

Authors:  T Zimmermann; E Kunisch; R Pfeiffer; A Hirth; H D Stahl; U Sack; A Laube; E Liesaus; A Roth; E Palombo-Kinne; F Emmrich; R W Kinne
Journal:  Arthritis Res       Date:  2000-11-21
View more
  30 in total

Review 1.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis.

Authors:  Xuling Huang; Courtney Brown; Weihua Ni; Elizabeth Maynard; Alan C Rigby; Peter Oettgen
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

Review 3.  The vasculature in rheumatoid arthritis: cause or consequence?

Authors:  Ewa M Paleolog
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

4.  Relationship of ultrasonographic findings with synovial angiogenesis modulators in different forms of knee arthritides.

Authors:  Mahmut Gok; Hakan Erdem; Feride Gogus; Sedat Yilmaz; Omer Karadag; Ismail Simsek; Rahsan Ilikci Sagkan; Mutlu Saglam; Ugur Musabak; Ayhan Dinc; Salih Pay
Journal:  Rheumatol Int       Date:  2012-07-19       Impact factor: 2.631

5.  Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis.

Authors:  P L E M van Lent; P N Span; A W Sloetjes; T R D J Radstake; A W T van Lieshout; J J T M Heuvel; C G J Sweep; W B van den Berg
Journal:  Ann Rheum Dis       Date:  2004-10-14       Impact factor: 19.103

6.  Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis.

Authors:  Yong Wook Park; Young Mo Kang; Joe Butterfield; Michael Detmar; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 7.  Angiogenesis and its targeting in rheumatoid arthritis.

Authors:  Zoltán Szekanecz; Alisa E Koch
Journal:  Vascul Pharmacol       Date:  2009-02-13       Impact factor: 5.773

8.  Treatment with anti-NAP monoclonal antibody reduces disease severity in murine model of novel angiogenic protein-induced or ovalbumin-induced arthritis.

Authors:  N B Nataraj; J Krishnamurthy; B P Salimath
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

9.  Angiopoietin-1 elicits pro-inflammatory responses in monocytes and differentiating macrophages.

Authors:  Seung Hyeok Seok; Jong-Ik Heo; Ji-Hye Hwang; Yi-Rang Na; Jang-Hyuk Yun; Eun Hui Lee; Jong-Wan Park; Chung-Hyun Cho
Journal:  Mol Cells       Date:  2013-05-16       Impact factor: 5.034

Review 10.  Angiogenesis in rheumatoid arthritis.

Authors:  Zoltán Szekanecz; Timea Besenyei; György Paragh; Alisa E Koch
Journal:  Autoimmunity       Date:  2009-11       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.